[186] BENEFIT OF PLASMAPHERESIS AND ANTICOAGULATION IN PATIENS TRANSPLANTED FOR END-STAGE LIVER DISEASE WITH HIGH RISK FOR ANTIPHOSPHOLIPID-ASSOCIATED VASCULAR EVENTS | Publicación